JULIETTE CARDENAS: Open Payments
NPI 1346730777 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 13 payments from 8 companies in 2025. Trend: 2023 $74 · 2024 $167 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $159 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Incyte Corporation | 2 | $52 |
| BeOne Medicines USA, Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| JAZZ PHARMACEUTICALS INC. | 1 | $15 |
Products named: RYBREVANT, PLUVICTO, MONJUVI, TEVIMBRA, Enhertu, Xospata, LYNOZYFIC, ZIIHERA.
Industry payments across FL — which companies pay providers there.
